CN110337695A - 基于业务单元数据特征的处方管控数据标准管理系统 - Google Patents
基于业务单元数据特征的处方管控数据标准管理系统 Download PDFInfo
- Publication number
- CN110337695A CN110337695A CN201680088713.5A CN201680088713A CN110337695A CN 110337695 A CN110337695 A CN 110337695A CN 201680088713 A CN201680088713 A CN 201680088713A CN 110337695 A CN110337695 A CN 110337695A
- Authority
- CN
- China
- Prior art keywords
- prescription
- dimension
- business unit
- hospital
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 150
- 229940079593 drug Drugs 0.000 claims abstract description 133
- 238000007726 management method Methods 0.000 claims abstract description 34
- 238000012550 audit Methods 0.000 claims abstract description 8
- 238000003908 quality control method Methods 0.000 claims abstract description 8
- 238000012545 processing Methods 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
- 238000004458 analytical method Methods 0.000 claims description 24
- 201000010099 disease Diseases 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 10
- 238000010606 normalization Methods 0.000 claims description 9
- 238000013439 planning Methods 0.000 claims description 9
- 230000008520 organization Effects 0.000 claims description 8
- 238000003745 diagnosis Methods 0.000 claims description 7
- 238000012954 risk control Methods 0.000 claims description 7
- 238000002483 medication Methods 0.000 claims description 5
- 238000012549 training Methods 0.000 claims description 5
- 238000011156 evaluation Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 208000017667 Chronic Disease Diseases 0.000 claims description 2
- 230000006399 behavior Effects 0.000 claims description 2
- 239000000599 controlled substance Substances 0.000 claims description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000002458 infectious effect Effects 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 230000003340 mental effect Effects 0.000 claims description 2
- 230000000144 pharmacologic effect Effects 0.000 claims description 2
- 230000000079 pharmacotherapeutic effect Effects 0.000 claims description 2
- 230000035935 pregnancy Effects 0.000 claims description 2
- 208000017520 skin disease Diseases 0.000 claims description 2
- 229960001957 stomatological preparations Drugs 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims 1
- 230000008676 import Effects 0.000 description 9
- 241001484259 Lacuna Species 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
Abstract
本发明涉及一种为处方合理性审核提供处方合理性管控数据标准的管理系统，该系统能够通过对区域或医疗机构一定时间一定数量的处方（包括医嘱）数据的处理，按照用户配置的业务单元，分析各业务单元处方信息所反映的处方合理性数据特征，并根据用户对业务单元处方质量管控目标的设定生成业务单元处方管控数据标准，以及生成相应的业务单元合理用药改进报告，最后由确认过的各业务单元处方管控数据标准集合成为该区域或医疗机构的处方合理性审核的整体管控数据标准。
Description
PCT国内申请，说明书已公开。
Claims (10)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2016/101123 WO2018058545A1 (zh) | 2016-09-30 | 2016-09-30 | 基于业务单元数据特征的处方管控数据标准管理系统 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110337695A true CN110337695A (zh) | 2019-10-15 |
Family
ID=61762318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680088713.5A Pending CN110337695A (zh) | 2016-09-30 | 2016-09-30 | 基于业务单元数据特征的处方管控数据标准管理系统 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN110337695A (zh) |
| WO (1) | WO2018058545A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112712864A (zh) * | 2021-01-07 | 2021-04-27 | 深圳坐标软件集团有限公司 | 一种可依据业务及政策配置规则的临床用药辅助方法及终端 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109544356B (zh) * | 2018-10-23 | 2023-10-20 | 平安医疗健康管理股份有限公司 | 一种基于数据处理的风险检测方法、装置及存储介质 |
| CN109544362A (zh) * | 2018-10-27 | 2019-03-29 | 平安医疗健康管理股份有限公司 | 一种基于风险管控的数据处理方法及设备 |
| CN110867237A (zh) * | 2019-11-15 | 2020-03-06 | 曹庆恒 | 一种对合理及合规用药系统的规则库进行管理的方法、系统和设备 |
| CN111986792B (zh) * | 2020-08-31 | 2024-04-05 | 平安医疗健康管理股份有限公司 | 医疗机构评分方法、装置、设备及存储介质 |
| CN112199493A (zh) * | 2020-10-16 | 2021-01-08 | 平安国际智慧城市科技股份有限公司 | 用药准确性确定方法、装置、电子设备及存储介质 |
| CN113314226A (zh) * | 2021-06-11 | 2021-08-27 | 曹庆恒 | 一种过敏反应智能分析的系统、方法和设备 |
| CN113643803B (zh) * | 2021-07-15 | 2022-06-07 | 上海交通大学医学院附属第九人民医院 | 口腔颌面头颈肿瘤智慧化康复随访系统 |
| CN113724829A (zh) * | 2021-08-30 | 2021-11-30 | 康键信息技术（深圳）有限公司 | 处方审核方法和装置、电子设备、存储介质 |
| CN113822365B (zh) * | 2021-09-28 | 2023-09-05 | 北京恒生芸泰网络科技有限公司 | 基于区块链技术的医疗数据存储及大数据挖掘方法及系统 |
| CN116894674A (zh) * | 2023-06-02 | 2023-10-17 | 华中科技大学同济医学院附属同济医院 | 一种订单拦截方法 |
| CN117151655B (zh) * | 2023-10-30 | 2024-01-23 | 天津市智恩博莱生物科技有限公司 | 一种用于多项目检测结果综合分析管理系统及方法 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5950630A (en) * | 1996-12-12 | 1999-09-14 | Portwood; Michael T. | System and method for improving compliance of a medical regimen |
| US20060265245A1 (en) * | 2004-12-29 | 2006-11-23 | Cerner Innovation, Inc. | System and methods for providing medication selection guidance |
| US20120109689A1 (en) * | 2010-10-28 | 2012-05-03 | Jason Lee | Support System for Improved Quality Healthcare |
| CN103854136A (zh) * | 2014-03-13 | 2014-06-11 | 华中科技大学同济医学院附属协和医院 | 带有用药安全监控干预功能的医院用药管理系统 |
| CN104463456A (zh) * | 2014-12-03 | 2015-03-25 | 长沙中科院文化创意与科技产业研究院 | 一种面向患者的医疗处方审核系统及其方法 |
| CN104487972A (zh) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | 一种多维度用药信息处理方法、系统和设备 |
| CN104809355A (zh) * | 2015-05-14 | 2015-07-29 | 天津智康医疗科技有限公司 | 一种基于任务调度的医疗处方规则审核引擎设计方法 |
| CN105224794A (zh) * | 2015-09-19 | 2016-01-06 | 石庆平 | 一种智能化处方审核系统及方法 |
| CN105550511A (zh) * | 2015-12-11 | 2016-05-04 | 北京锐软科技股份有限公司 | 一种基于数据校验技术的数据质量测评系统及方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104933324A (zh) * | 2015-07-10 | 2015-09-23 | 庞健 | 处方用药识别方法及系统 |
-
2016
- 2016-09-30 WO PCT/CN2016/101123 patent/WO2018058545A1/zh active Application Filing
- 2016-09-30 CN CN201680088713.5A patent/CN110337695A/zh active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5950630A (en) * | 1996-12-12 | 1999-09-14 | Portwood; Michael T. | System and method for improving compliance of a medical regimen |
| US20060265245A1 (en) * | 2004-12-29 | 2006-11-23 | Cerner Innovation, Inc. | System and methods for providing medication selection guidance |
| US20120109689A1 (en) * | 2010-10-28 | 2012-05-03 | Jason Lee | Support System for Improved Quality Healthcare |
| CN103854136A (zh) * | 2014-03-13 | 2014-06-11 | 华中科技大学同济医学院附属协和医院 | 带有用药安全监控干预功能的医院用药管理系统 |
| CN104487972A (zh) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | 一种多维度用药信息处理方法、系统和设备 |
| CN104463456A (zh) * | 2014-12-03 | 2015-03-25 | 长沙中科院文化创意与科技产业研究院 | 一种面向患者的医疗处方审核系统及其方法 |
| CN104809355A (zh) * | 2015-05-14 | 2015-07-29 | 天津智康医疗科技有限公司 | 一种基于任务调度的医疗处方规则审核引擎设计方法 |
| CN105224794A (zh) * | 2015-09-19 | 2016-01-06 | 石庆平 | 一种智能化处方审核系统及方法 |
| CN105550511A (zh) * | 2015-12-11 | 2016-05-04 | 北京锐软科技股份有限公司 | 一种基于数据校验技术的数据质量测评系统及方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112712864A (zh) * | 2021-01-07 | 2021-04-27 | 深圳坐标软件集团有限公司 | 一种可依据业务及政策配置规则的临床用药辅助方法及终端 |
| CN112712864B (zh) * | 2021-01-07 | 2024-03-29 | 深圳坐标软件集团有限公司 | 一种可依据业务及政策配置规则的临床用药辅助方法及终端 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018058545A1 (zh) | 2018-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110337695A (zh) | 基于业务单元数据特征的处方管控数据标准管理系统 | |
| Valderas et al. | Quality of care assessment for people with multimorbidity | |
| Purpura et al. | The role of real‐world evidence in FDA‐approved new drug and biologics license applications | |
| Ross et al. | What is the scale of prescribing errors committed by junior doctors? A systematic review | |
| Goddard et al. | Automation bias: empirical results assessing influencing factors | |
| Zhang et al. | Pharmacovigilance in China: current situation, successes and challenges | |
| CN110024039A (zh) | 处方用药信息合理性数据特征分析系统 | |
| CN110867237A (zh) | 一种对合理及合规用药系统的规则库进行管理的方法、系统和设备 | |
| Conn et al. | Healthcare provider targeted interventions to improve medication adherence: systematic review and meta‐analysis | |
| Gazarian et al. | Long-term reduction in adverse drug events: an evidence-based improvement model | |
| Thompson | Replication of randomized, controlled trials using real-world data: what could go wrong? | |
| Smith et al. | Advancing the field of pharmaceutical risk minimization through application of implementation science best practices | |
| Brown et al. | Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system | |
| Dobel‐Ober et al. | Nurse prescribing in mental health: national survey | |
| Panesar et al. | Patient safety and healthcare improvement at a glance | |
| Dionisi et al. | Medication errors' causes analysis in home care setting: A systematic review | |
| He et al. | Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China | |
| Boocock et al. | Clinicians’ perceived barriers and enablers to the dietary management of adults with type 2 diabetes in primary care: A systematic review | |
| Sassoli et al. | Understanding pharmacist communication and medication errors: A systematic literature review | |
| Li et al. | Questionnaires measuring patient participation in patient safety—a systematic review | |
| He et al. | Examination of psychosocial predictors of Chinese hospital pharmacists' intention to provide clinical pharmacy services using the theory of planned behaviour: a cross-sectional questionnaire study | |
| Weekes et al. | Indicators for drug and therapeutics committees | |
| Geeson et al. | High‐risk medicines associated with clinically relevant medication‐related problems in UK hospitals: A prospective observational study | |
| Kraft et al. | Parenteral nutrition prescribing and order review safety study: the need for pharmacist intervention | |
| El-Den et al. | Pharmacists’ roles in supporting people living with severe and persistent mental illness: a systematic review protocol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |